EcoDrugPlus

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOTSG00005014803
Gene Symbol: AVPR1A
1 Cross references
139 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOTSG00005008183
Gene Symbol: AVPR1A
1 Cross references
187 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOTSG00005040954
Gene Symbol: AVPR1A
1 Cross references
139 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSOTSG00005010398
Gene Symbol: AVPR2
1 Cross references
172 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSOTSG00005045777
Gene Symbol: AVPR2
1 Cross references
172 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSOTSG00005011105
Gene Symbol: LOC112232405
3 Cross references
186 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 3-Like

Ensembl ID : ENSOTSG00005007973
Gene Symbol: LOC112249635
2 Cross references
204 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSOTSG00005007980
Gene Symbol: AURKA
1 Cross references
233 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSOTSG00005039726
Gene Symbol: LOC112252665
3 Cross references
200 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSOTSG00005023508
Gene Symbol: LOC112218878
3 Cross references
199 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSOTSG00005009579
Gene Symbol: LOC112215997
3 Cross references
221 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSOTSG00005031878
Gene Symbol: LOC112262922
3 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).